DOPPS estimates of patient life years attributable to modifiable hemodialysis practices in the United States

被引:94
作者
Port, FK
Pisoni, RL
Bragg-Gresham, JL
Satayathum, SS
Young, EW
Wolfe, RA
Held, PJ
机构
[1] Univ Michigan, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA
[2] Univ Renal Res & Educ Assoc, Ann Arbor, MI USA
关键词
hemodialysis; practice patterns; Kidney Disease Outcomes Quality Initiative; European Best Practices Guidelines for Hemodialysis; Dialysis Outcomes and Practice Patterns Study; hyperphosphatemia; albumin; anemia;
D O I
10.1159/000074938
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Data from the Dialysis Outcomes and Practice Patterns Study (DOPPS) allow estimation of the percentage of patients outside published hemodialysis guidelines and their associated mortality risk. We estimated the number of life years that could be gained from adherence to four of these guidelines and two other modifiable practices, i.e. dialysis dose, phosphate control, improved anemia, partial correction of serum albumin, reduced interdialytic weight gain and less use of catheters for vascular access. We extrapolated DOPPS data on these practices and guidelines to the US hemodialysis population for a 5-year projected period. Of the practices we examined, the highest relative risk of mortality was associated with having albumin <3.5 g/dl (relative risk = 1.38, p < 0.0001); 20.5% of the patients in the study fell outside the target range. The adjusted sum of the patient years attributable to all six practice patterns was 143,617; a more conservative estimate, modeling life years potentially gained by bringing half of all patients outside targets within them, is 69,367. The magnitude of potential savings in life years should encourage greater adherence to guidelines and practices that are significantly associated with better survival. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 23 条
[1]
Combe C, 2001, NEPHROLOGIE, V22, P379
[2]
DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205
[3]
Type of vascular access and mortality in US hemodialysis patients [J].
Dhingra, RK ;
Young, EW ;
Hulbert-Shearon, TE ;
Leavey, SF ;
Port, FK .
KIDNEY INTERNATIONAL, 2001, 60 (04) :1443-1451
[4]
European Best Practice Guidelines for Haemodialysis, 2002, NEPHROL DIAL TRAN S7, V17, P1
[5]
HECKING E, IN PRESS NEPHROL DIA
[6]
The dose of hemodialysis and patient mortality [J].
Held, PJ ;
Port, FK ;
Wolfe, RA ;
Stannard, DC ;
Carroll, CE ;
Daugirdas, JT ;
Bloembergen, WE ;
Greer, JW ;
Hakim, RM .
KIDNEY INTERNATIONAL, 1996, 50 (02) :550-556
[7]
KLEIN JP, 1997, SURVIVAL ANAL TECHNI, P417
[8]
LOCATELLI F, IN PRESS NEPHROL DIA
[9]
Health-related quality of life as a predictor of mortality and hospitalization: The Dialysis Outcomes and Practice Patterns Study (DOPPS) [J].
Mapes, DL ;
Lopes, AA ;
Satayathum, S ;
McCullough, KP ;
Goodkin, DA ;
Locatelli, F ;
Fukuhara, S ;
Young, EW ;
Kurokawa, K ;
Saito, A ;
Bommer, J ;
Wolfe, RA ;
Held, PJ ;
Port, FK .
KIDNEY INTERNATIONAL, 2003, 64 (01) :339-349
[10]
*NAT KIDN FDN, 2001, AM J KIDNEY DIS S, V37, pS1